{"id":"https://openalex.org/W3180787635","doi":"https://doi.org/10.1080/14740338.2021.1952981","title":"Comprehensive evaluation of post-approval regulatory actions during the drug lifecycle \u2013 a focus on benefits and risks","display_name":"Comprehensive evaluation of post-approval regulatory actions during the drug lifecycle \u2013 a focus on benefits and risks","publication_year":2021,"publication_date":"2021-07-15","ids":{"openalex":"https://openalex.org/W3180787635","doi":"https://doi.org/10.1080/14740338.2021.1952981","mag":"3180787635","pmid":"https://pubmed.ncbi.nlm.nih.gov/34263667"},"language":"en","primary_location":{"id":"doi:10.1080/14740338.2021.1952981","doi":"https://doi.org/10.1080/14740338.2021.1952981","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14740338.2021.1952981","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1952981?needAccess=true","source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1952981?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036228687","display_name":"Lourens T. Bloem","orcid":"https://orcid.org/0000-0002-0014-8625","observed_orcids":["https://orcid.org/0000-0002-0014-8625"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Lourens T. Bloem","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","Pharmacovigilance department, Dutch Medicines Evaluation Board, Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-0014-8625","affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Pharmacovigilance department, Dutch Medicines Evaluation Board, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040812145","display_name":"Mariana Karomi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Mariana Karomi","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018966174","display_name":"Jarno Hoekman","orcid":"https://orcid.org/0000-0002-2817-1229","observed_orcids":["https://orcid.org/0000-0002-2817-1229"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jarno Hoekman","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","Pharmacovigilance department, Innovation Studies, Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Pharmacovigilance department, Innovation Studies, Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044693996","display_name":"Menno E. van der Elst","orcid":"https://orcid.org/0009-0005-6151-6419","observed_orcids":["https://orcid.org/0009-0005-6151-6419"]},"institutions":[{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Menno E. van der Elst","raw_affiliation_strings":["Pharmacovigilance department, Dutch Medicines Evaluation Board, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacovigilance department, Dutch Medicines Evaluation Board, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035747289","display_name":"Hubert G. M. Leufkens","orcid":"https://orcid.org/0000-0002-7175-1499","observed_orcids":["https://orcid.org/0000-0002-7175-1499"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hubert G.M. Leufkens","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038962814","display_name":"Olaf H. Klungel","orcid":"https://orcid.org/0000-0002-5604-813X","observed_orcids":["https://orcid.org/0000-0002-5604-813X"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]},{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["DK","NL"],"is_corresponding":false,"raw_author_name":"Olaf H. Klungel","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark","institution_ids":["https://openalex.org/I177969490"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041722553","display_name":"Aukje Kaija Mantel-Teeuwisse","orcid":"https://orcid.org/0000-0002-8782-0698","observed_orcids":["https://orcid.org/0000-0002-8782-0698"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Aukje K. Mantel-Teeuwisse","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-8782-0698","affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5036228687"],"corresponding_institution_ids":["https://openalex.org/I193662353","https://openalex.org/I4210150351"],"apc_list":null,"apc_paid":null,"fwci":0.9776,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.67516728,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"20","issue":"11","first_page":"1433","last_page":"1442"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-life-cycle","display_name":"drug life cycle","score":0.7620000243186951},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7139999866485596},{"id":"https://openalex.org/keywords/drug-benefits","display_name":"drug benefits","score":0.503000020980835},{"id":"https://openalex.org/keywords/european-medicines-agency","display_name":"European Medicines Agency","score":0.7919999957084656},{"id":"https://openalex.org/keywords/regulatory-learning","display_name":"regulatory learning","score":0.671999990940094},{"id":"https://openalex.org/keywords/patient-exposure","display_name":"patient exposure","score":0.6010000109672546},{"id":"https://openalex.org/keywords/risk-characterization","display_name":"risk characterization","score":0.5640000104904175},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.4050000011920929}],"concepts":[{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.7426127791404724},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7397974729537964},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.600831925868988},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.5189499855041504},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.5021934509277344},{"id":"https://openalex.org/C191160116","wikidata":"https://www.wikidata.org/wiki/Q3423709","display_name":"Regulatory focus theory","level":3,"score":0.4733864367008209},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.46106868982315063},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4372403025627136},{"id":"https://openalex.org/C2991908516","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory authority","level":2,"score":0.41376349329948425},{"id":"https://openalex.org/C2780451532","wikidata":"https://www.wikidata.org/wiki/Q759676","display_name":"Task (project management)","level":2,"score":0.07842400670051575},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C3116431","wikidata":"https://www.wikidata.org/wiki/Q31728","display_name":"Public administration","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D004335","descriptor_name":"Drug and Narcotic Control","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D004348","descriptor_name":"Drug Labeling","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006077","descriptor_name":"Government Agencies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1080/14740338.2021.1952981","doi":"https://doi.org/10.1080/14740338.2021.1952981","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14740338.2021.1952981","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1952981?needAccess=true","source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},{"id":"pmid:34263667","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34263667","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug safety","raw_type":"Journal Article"},{"id":"pmh:oai:dspace.library.uu.nl:1874/413000","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/413000","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:figshare.com:article/14987862","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Comprehensive_evaluation_of_post-approval_regulatory_actions_during_the_drug_lifecycle_a_focus_on_benefits_and_risks/14987862","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:sdu.dk:openaire/078bbb98-b15b-42e3-98c7-da16a241f3aa","doi":null,"is_oa":true,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/078bbb98-b15b-42e3-98c7-da16a241f3aa","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Bloem, L T, Karomi, M, Hoekman, J, van der Elst, M E, Leufkens, H G M, Klungel, O H & Mantel-Teeuwisse, A K 2021, 'Comprehensive evaluation of post-approval regulatory actions during the drug lifecycle\u2013a focus on benefits and risks', Expert Opinion on Drug Safety, vol. 20, no. 11, pp. 1433-1442. https://doi.org/10.1080/14740338.2021.1952981","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:uu:oai:dspace.library.uu.nl:1874/413000","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/413000","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Opinion on Drug Safety, 20(11), 1433. Informa Healthcare","raw_type":"info:eu-repo/semantics/article"},{"id":"doi:10.6084/m9.figshare.14987862.v1","doi":"https://doi.org/10.6084/m9.figshare.14987862.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.14987862.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.1080/14740338.2021.1952981","doi":"https://doi.org/10.1080/14740338.2021.1952981","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14740338.2021.1952981","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1952981?needAccess=true","source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3180787635.pdf","grobid_xml":"https://content.openalex.org/works/W3180787635.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W2032805806","https://openalex.org/W2038442082","https://openalex.org/W2067460372","https://openalex.org/W2090226269","https://openalex.org/W2091112596","https://openalex.org/W2110240727","https://openalex.org/W2116445878","https://openalex.org/W2134863878","https://openalex.org/W2182442935","https://openalex.org/W2269807470","https://openalex.org/W2336066991","https://openalex.org/W2346546827","https://openalex.org/W2422355671","https://openalex.org/W2581623376","https://openalex.org/W2602824263","https://openalex.org/W2612600212","https://openalex.org/W2620558218","https://openalex.org/W2736849112","https://openalex.org/W2738680803","https://openalex.org/W2750636690","https://openalex.org/W2777434883","https://openalex.org/W2778128190","https://openalex.org/W2792149749","https://openalex.org/W2798053807","https://openalex.org/W2803144468","https://openalex.org/W2885739590","https://openalex.org/W2893780548","https://openalex.org/W2906909555","https://openalex.org/W2907166494","https://openalex.org/W2910326837","https://openalex.org/W2979054698","https://openalex.org/W2980987763","https://openalex.org/W2982357578","https://openalex.org/W2982369322","https://openalex.org/W2996319370","https://openalex.org/W2996690001","https://openalex.org/W3010881191","https://openalex.org/W3011361033","https://openalex.org/W3035992474"],"related_works":["https://openalex.org/W2757847509","https://openalex.org/W2890950316","https://openalex.org/W1520666503","https://openalex.org/W2610577735","https://openalex.org/W2068680769","https://openalex.org/W2057225883","https://openalex.org/W2091112596","https://openalex.org/W2184317324","https://openalex.org/W2067460372","https://openalex.org/W1518973034"],"abstract_inverted_index":{"Background:":[0],"Prior":[1],"studies":[2],"investigated":[3],"regulatory":[4,20,57,87,146,156,162,193],"actions":[5,21,163],"that":[6,22,80],"reflected":[7,23,106,134,164],"a":[8,24,107,116,135,159,165],"negative":[9,25,117],"impact":[10,28,63,167,192],"on":[11,29,64,168],"drug":[12,75,121,184],"risks.":[13,171],"We":[14,42,59,89],"aimed":[15],"to":[16,55,83,153],"evaluate":[17],"occurrence":[18],"of":[19,86,140,155,161],"or":[26,31,53,66],"positive":[27,108,166],"benefits":[30,65,169,176],"risks,":[32],"as":[33,35],"well":[34],"relations":[36,69],"between":[37,70],"them.Research":[38],"design":[39],"and":[40,68,93,113,148,170,177,195],"methods:":[41],"followed":[43],"EMA-approved":[44],"innovative":[45],"drugs":[46],"from":[47],"approval":[48],"(2009\u20132010)":[49],"until":[50],"July":[51],"2020":[52],"withdrawal":[54],"identify":[56],"actions.":[58,71],"assessed":[60],"these":[61,133],"for":[62,77,97,145,183],"risks":[67,150,178],"Additionally,":[72],"we":[73],"scrutinized":[74],"lifecycles":[76],"time-variant":[78],"characteristics":[79],"may":[81,151,191],"contribute":[82,152],"specific":[84],"patterns":[85,154],"actions.Results:":[88],"identified":[90],"14":[91],"letters":[92],"361":[94],"label":[95,102],"updates":[96,124],"40":[98],"drugs.":[99],"Of":[100],"the":[101],"updates,":[103,130],"85":[104],"(24%)":[105],"impact,":[109,118],"mostly":[110,119],"concerning":[111],"indications,":[112],"276":[114],"(76%)":[115],"adverse":[120],"reactions.":[122],"Many":[123],"(54%)":[125],"occurred":[126],"simultaneously":[127],"with":[128],"other":[129],"also":[131],"if":[132],"different":[136],"impact.":[137],"Furthermore,":[138],"levels":[139],"patient":[141],"exposure,":[142],"innovativeness,":[143],"needs":[144],"learning":[147,174],"unexpected":[149],"actions.Conclusions:":[157],"Almost":[158],"quarter":[160],"Also,":[172],"simultaneous":[173],"about":[175],"suggests":[179],"an":[180],"important":[181],"role":[182],"development":[185],"in":[186],"risk":[187],"characterization.":[188],"These":[189],"findings":[190],"analyses":[194],"decision-making.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-07-19T00:00:00"}